Leukemia Clinical Trials in Los Angeles

Showing 1381-1400 of 1,416 trials

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

NCT00516100

Pemetrexed is an FDA-approved treatment for advanced lung cancer but the response rate is still very low. Bortezomib is currently approved to treat myeloma in patients who have already been treated. Currently, multiple studies are actively investigating how well bortezomib works with other drugs. This study is testing how much bortezomib can be given to advanced lung cancer patients who have already received one treatment. This study will also see how well bortezomib and pemetrexed work together to treat lung cancer patients.

Non-small Cell Lung Cancer

Aptium Oncology Research Network62 participantsStarted Jan 2006

Los Angeles, California, United States • Palm Springs, California, United States • San Francisco, California, United States +1 more locations

COMPLETEDPhase 1/2< 1 mile

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

NCT00363974

The purpose of this study is to determine if the drug, called AEG35156, can be safely given to AML patients and whether it effectively reduces levels of a protein (XIAP) to increase the sensitivity of cancer cells to chemotherapy (ara-C and idarubicin) in patients with refractory or relapsed AML.

Leukemia, Myelomonocytic, Acute

Aegera Therapeutics54 participantsStarted Oct 2005

Los Angeles, California, United States • Los Angeles, California, United States • Chicago, Illinois, United States +4 more locations

UNKNOWNPhase 2< 1 mile

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00964132

The purpose of this study is to determine whether NRX 194204 is effective in the treatment of advanced Non-Small Cell Lung Cancer (NSCLC).

Non-small Cell Lung Cancer

NuRx Pharmaceuticals, Inc.48 participantsStarted Mar 2009

Fountain Valley, California, United States • La Jolla, California, United States • Los Angeles, California, United States +3 more locations

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Leukemia Trials in Other Cities

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

CPG 7909 Injection in Non-Small Cell Lung Cancer

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

An Autism Study Using Nambudripad's Food Allergy Elimination Treatments

A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

Other Conditions in Los Angeles